New Method Simplifies Testing of HDL Function in Heart Disease Study
A simplified test of HDL's ability to remove cholesterol was associated with high-risk coronary plaques in a study of 61 patients.
A simplified test of HDL's ability to remove cholesterol was associated with high-risk coronary plaques in a study of 61 patients.
HerAnova Lifesciences has launched HerResolve, the first blood-based test for endometriosis detection, at IVF centers nationwide. Validation studies show diagnostic accuracy comparable to surgical standards, according to the company.
The test uses microRNA analysis and AI to diagnose endometriosis in women with chronic pelvic pain when imaging is inconclusive.
Researchers have developed a highly sensitive, pregnancy-test-like diagnostic device that uses menstrual blood to detect endometriosis early.
Read MoreJuniper Genomics has launched publicly to offer a next-generation embryo screening platform that aims to improve IVF outcomes.
Read MoreJoin Tosoh Bioscience and Dr. Giuliana Puccini Santamaria for a deep dive into fertility markers and their role in diagnosing and managing infertility. This webinar explores key indicators like ovarian function, polycystic ovarian syndrome, and the importance of fast, accurate immunoassay results in fertility treatment. Ideal for clinicians seeking actionable insights in reproductive health.
Read MoreInnovative IVF techniques are emerging to improve implantation predictions through non-invasive, AI-driven metabolomics assays.
Read Morehc1 has launched HerCare, a new module in its MyBloodHealth platform, to enhance maternal health by providing real-time lab-driven insights.
Read MoreA Brazilian study used metabolomic analysis to identify metabolic alterations associated with different severities of preeclampsia.
Read MoreThe vaginal microbiome is a complex and dynamic ecosystem that varies across populations; research is limited by geographical disparities.
Read MoreYourgene Health has launched IONA Care+, a comprehensive non-invasive prenatal screening service in the UK, expanding its NIPT offerings.
Read MoreRoche’s Elecsys sFlt-1/PlGF test received FDA clearance, providing a prognostic way to help ID pregnant women at risk of severe preeclampsia.
Read MoreA new study suggests that neuroactive steroid levels in the third trimester may predict postpartum depression risk.
Read MoreThe Mirvie RNA platform identified a unique molecular signature predictive of severe fetal growth restriction, allowing early detection.
Read MoreNew research reveals that the saliva of pregnant women shows differences in their oral microbiome based on their levels of life stress.
Read MoreA study found that faster blood processing could double the detection of gestational diabetes, reducing complications for mothers and babies.
Read MoreNIH researchers found undetected cancers in nearly half of pregnant people with abnormal prenatal cfDNA test results.
Read MoreResearchers identified genes closely linked to both rheumatoid arthritis and osteoporosis, offering diagnostic markers for these diseases.
Read More